Effect of conjugated bilirubin on clinical outcomes in infective endocarditis

No abstract is available for this paper.

• Publication year

  2019

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2019-08-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10096-019-03670-4PMID 31428896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of admission neutrophil-to-platelet ratio on in-hospital and long-term mortality in patients with infective endocarditis

  2017cited by this paper
• Usefulness of the Direct and/or Total Bilirubin to Predict Adverse Outcomes in Patients With Acute Decompensated Heart Failure.

  2017cited by this paper
• Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma.

  2017cited by this paper
• Challenges in Infective Endocarditis.

  2017cited by this paper
• A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis. The EndoSCORE.

  2017cited by this paper
• The Association of Serum Bilirubin Levels on the Outcomes of Severe Sepsis

  2015cited by this paper
• Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation.

  2015cited by this paper
• Abstract 19408: Impact of Perioperative Liver Dysfunction on In-hospital Mortality and Long-term Survival in Infective Endocarditis Patients

  2015cited by this paper
• Bilirubin inhibits the up-regulation of inducible nitric oxide synthase by scavenging reactive oxygen species generated by the toll-like receptor 4-dependent activation of NADPH oxidase

  2015cited by this paper
• Conjugated Bilirubin Triggers Anemia by Inducing Erythrocyte Death

  2014cited by this paper
• Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study.

  2014cited by this paper
• Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure.

  2013cited by this paper
• Cardiohepatic interactions in heart failure: an overview and clinical implications.

  2013cited by this paper
• Myocardial oxidative stress in patients with active infective endocarditis.

  2013cited by this paper
• Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance

  2012cited by this paper
• Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis

  2009cited by this paper
• Sepsis‐induced cholestasis

  2007cited by this paper
• Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators.

  2006cited by this paper
• Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.

  2006cited by this paper
• Unconjugated Bilirubin Inhibits VCAM-1-Mediated Transendothelial Leukocyte Migration1

  2005cited by this paper
• Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats

  2004cited by this paper
• Liver dysfunction and heart failure.

  2003cited by this paper
• AGA technical review on the evaluation of liver chemistry tests.

  2002cited by this paper
• The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction

  2002cited by this paper
• The causes of obvious jaundice in South West Wales: perceptions versus reality

  2001cited by this paper
• Serial evaluation of the SOFA score to predict outcome in critically ill patients.

  2001cited by this paper
• Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

  2000cited by this paper
• Studies on the elimination of bilirubin pre-operatively in patients with mitral valve disease.

  1994cited by this paper

• A Case Report of Infective Endocarditis With Icterus

  2025cites this paper
• ASSESS-IE: a Novel Risk Score for Patients with Infective Endocarditis

  2023cites this paper
• Commentary: Risk stratification in infective endocarditis: The emerging role of the liver-heart-kidney axis.

  2022cites this paper
• Isolated mitral valve endocarditis: Patient, disease, and surgical factors that influence outcomes.

  2022cites this paper
• Bilirubin in metabolic syndrome and associated inflammatory diseases: New perspectives.

  2020cites this paper
• Commentary: Risk strati fi cation in infective endocarditis: The emerging role of the liver – heart – kidney axis

  year unknowninfluential citation